| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the … P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ... European heart journal 37 (27), 2129-2200, 2016 | 25904* | 2016 |
| Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 2092 | 2021 |
| Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease D Fatkin, C MacRae, T Sasaki, MR Wolff, M Porcu, M Frenneaux, ... New England Journal of Medicine 341 (23), 1715-1724, 1999 | 1608 | 1999 |
| Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial K Fox, I Ford, PG Steg, M Tendera, R Ferrari The Lancet 372 (9641), 807-816, 2008 | 1512 | 2008 |
| Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised … K Fox, I Ford, PG Steg, M Tendera, M Robertson, R Ferrari The Lancet 372 (9641), 817-821, 2008 | 1052 | 2008 |
| A prospective study of sudden cardiac death among children and young adults RD Bagnall, RG Weintraub, J Ingles, J Duflou, L Yeates, L Lam, AM Davis, ... New England Journal of Medicine 374 (25), 2441-2452, 2016 | 865 | 2016 |
| Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy B Gerull, M Gramlich, J Atherton, M McNabb, K Trombitás, ... Nature genetics 30 (2), 201-204, 2002 | 753 | 2002 |
| Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... New England Journal of Medicine 384 (2), 105-116, 2021 | 602 | 2021 |
| Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure M Packer, W Colucci, L Fisher, BM Massie, JR Teerlink, J Young, ... JACC: Heart Failure 1 (2), 103-111, 2013 | 539 | 2013 |
| National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018 JJ Atherton, A Sindone, CG De Pasquale, A Driscoll, PS MacDonald, ... Heart, Lung and Circulation 27 (10), 1123-1208, 2018 | 440 | 2018 |
| Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with … B Pieske, AP Maggioni, CSP Lam, E Pieske-Kraigher, G Filippatos, ... European heart journal 38 (15), 1119-1127, 2017 | 402 | 2017 |
| Hierarchical layered double hydroxide nanocomposites: structure, synthesis and applications Z Gu, JJ Atherton, ZP Xu Chemical Communications 51 (15), 3024-3036, 2015 | 396 | 2015 |
| Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage N Parekh, B Venkatesh, D Cross, A Leditschke, J Atherton, W Miles, ... Journal of the American College of Cardiology 36 (4), 1328-1335, 2000 | 315 | 2000 |
| Heart failure care in low-and middle-income countries: a systematic review and meta-analysis T Callender, M Woodward, G Roth, F Farzadfar, JC Lemarie, S Gicquel, ... PLoS medicine 11 (8), e1001699, 2014 | 298 | 2014 |
| Long-term trends in antidiabetes drug usage in the US: real-world evidence in patients newly diagnosed with type 2 diabetes O Montvida, J Shaw, JJ Atherton, F Stringer, SK Paul Diabetes care 41 (1), 69-78, 2018 | 285 | 2018 |
| The continuous heart failure spectrum: moving beyond an ejection fraction classification F Triposkiadis, J Butler, FM Abboud, PW Armstrong, S Adamopoulos, ... European heart journal 40 (26), 2155-2163, 2019 | 275 | 2019 |
| Diastolic ventricular interaction in chronic heart failure JJ Atherton, TD Moore, SS Lele, HL Thomson, AJ Galbraith, I Belenkie, ... The Lancet 349 (9067), 1720-1724, 1997 | 268 | 1997 |
| Effects of serelaxin in patients with acute heart failure M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... New England Journal of Medicine 381 (8), 716-726, 2019 | 264 | 2019 |
| Angiotensin receptor–neprilysin inhibition in acute myocardial infarction MA Pfeffer, B Claggett, EF Lewis, CB Granger, L Køber, AP Maggioni, ... New England Journal of Medicine 385 (20), 1845-1855, 2021 | 250 | 2021 |
| Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications J Ingles, C Burns, RD Bagnall, L Lam, L Yeates, T Sarina, R Puranik, ... Circulation: Cardiovascular Genetics 10 (2), e001620, 2017 | 217 | 2017 |
